Post-Translational Modification Compound Library

Catalog No. L1620

Post-Translational Modification (PTM) refers to a series of chemical modifications that proteins undergo after synthesis. These modifications can significantly alter the structure, function, and localization of proteins, thereby playing key roles in various biological processes such as cell signaling, metabolic regulation, and stress response. Common post-translational modifications include phosphorylation, acetylation, ubiquitination, and glycosylation. Studies have shown that abnormalities in PTMs are closely associated with the onset and progression of many diseases, such as cancer, neurodegenerative disorders (including Alzheimer’s disease and Parkinson’s disease), diabetes, and cardiovascular diseases.
The Post-Translational Modification Compound Library contains 3490 small molecule bioactive compounds. This library includes modulators that regulate the activity of PTM-related enzymes, such as kinases, acetyltransferases, and ubiquitin ligases. It can be widely applied in studies of signaling pathway mechanisms, new target discovery and validation, as well as high-throughput drug screening, making it an effective tool for PTM research and drug discovery.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.